Defective Drugs

We Care
and
It Shows

Defective Drugs

Zofran® taken during pregnancy may increase the risk of birth defects.


According to recent studies, Zofran® (ondansetron), a commonly prescribed medication used to aid morning sickness in pregnant women, may increase the risk of having a baby with a birth defect by as much as 30%. Pregnant women who take Zofran® may give birth to babies with a heart defect, cleft lip, cleft palate or other birth defect.  You and your child may be entitled to compensation for the injuries Zofran® caused.

Zofran® (ondansetron) is a prescription anti-nausea medication manufactured by GlaxoSmithKline. It was FDA approved in 1991 for the prevention of nausea and vomiting for patients recovering from surgery or chemotherapy.  Zofran® has never been approved by the FDA for the treatment of morning sickness but was often prescribed “off label” to pregnant women. Taking Zofran® during pregnancy, especially the first trimester, has been linked to various birth defects.

Zofran® taken during pregnancy may increase the risk of the following:

  • Heart defects
  • Heart murmur
  • Atrial septal defect
  • Cleft lip
  • Cleft palate
  • Fetal growth restriction
  • Jaundice
  • Kidney defects
  • Pregnancy complications
  • Death
  • Other birth defects

Zofran Birth Defect Attorneys

If you or a loved one took Zofran® during pregnancy and gave birth to a baby with a birth defect, call now to speak to a lawyer at our firm. You may be entitled to compensation by filing a lawsuit.  Thomas & Wan has handled many defective drug cases nationwide.  Our attorneys will fight for you and your child’s rights.